CJC-1295 5mg + Ipamorelin 5mg is a research peptide blend commonly studied for its potential to support growth hormone release through complementary mechanisms. CJC-1295 is investigated for its interaction with growth hormone-releasing hormone (GHRH) pathways, while Ipamorelin is studied for its selective stimulation of growth hormone secretion through ghrelin receptors. Together, they are widely researched for their potential effects on muscle development, recovery, body composition, metabolic function, sleep quality, and tissue regeneration. This combination has become a valuable tool in laboratory studies focused on endocrine function, aging, performance, and regenerative research.
This product is intended strictly for educational and laboratory research use and is not approved for human consumption or clinical applications.